Kevin美股成长价投2019-12-31 06:31
$Orgenesis(ORGS)$ $BioLife Solutions(BLFS)$ 近几年美国细胞治疗和再生医学领域发展迅速,投入资本年增长速度超过20%,Orgs为其它公司提供研发服务。算是这波细胞治疗和再生医学淘金热潮里卖铲子的商家。所以近几年公司录的非常稳定而高速的营收增长。股价从高位大幅调整下来,已经开始修复,目...查看全文
牛唐2019-10-11 22:12
$BioLife Solutions(BLFS)$ 全部收购了SAVSU,受益于细胞疗法的火热,2019年收入指引是增长39%,毛利率是七成左右,目前股价回调的厉害,可以关注查看全文
$BioLife Solutions(BLFS)$ 内部交易: 2021-01-15,10% Owner,VILLIGER WALTER ,卖出,29338普通股, $40.62
$BioLife Solutions(BLFS)$ 内部交易: 2021-01-14,10% Owner,VILLIGER WALTER ,卖出,22152普通股, $43.08
$BioLife Solutions(BLFS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-000907 Size: 7 KB 网页链接
$BioLife Solutions(BLFS)$ 内部交易: 2021-01-12,10% Owner,VILLIGER WALTER ,卖出,8435普通股, $40.40
$BioLife Solutions(BLFS)$ 内部交易: 2021-01-11,10% Owner,VILLIGER WALTER ,卖出,80000普通股, $40.24
$BioLife Solutions(BLFS)$ 内部交易: 2021-01-08,副总裁, Global Sales,Schulz Marcus ,卖出,293普通股, $39.01
$BioLife Solutions(BLFS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-000682 Size: 10 KB 网页链接
$BioLife Solutions(BLFS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-000683 Size: 4 KB 网页链接
$BioLife Solutions(BLFS)$ 内部交易: 2021-01-07,10% Owner,VILLIGER WALTER ,卖出,30000普通股, $39.55
$BioLife Solutions(BLFS)$ 内部交易: 2021-01-06,10% Owner,VILLIGER WALTER ,卖出,15075普通股, $41.53